SC
EVH icon

Shay Capital’s Evolent Health EVH Stock Holding History

Shay Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-187,600
Closed -$5.31M – 344
2024
Q3 		$5.31M Buy
+187,600
New +$4.84M 0.75% 24

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shay Capital's EVH Position: Q1 2026 in Review

Shay Capital reduced its Evolent Health (EVH) stake by 72% in Q1 2026, selling an estimated $95.2K and leaving 11,514 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Shay Capital first reported a position in EVH in Q3 2024 and has held it in 5 quarters since. The position peaked at $6.72M in Q3 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Shay Capital held 11,514 shares of Evolent Health worth $26.3K as of Q1 2026.
  • Shay Capital sold 30,000 Evolent Health shares in Q1 2026, an estimated $95.2K.
  • Evolent Health made up ﹤0.01% of Shay Capital's portfolio in Q1 2026, its #463 holding.
  • Shay Capital first reported a position in Evolent Health in Q3 2024 and has held it in 5 quarters since.
  • Shay Capital's Evolent Health position peaked at $6.72M in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.